FDA Advisory Panel Votes Against Blanket Booster but for Third Shot for Elderly, Those at High Risk of Severe COVID-19

September 17th 2021

Committee's two votes are only recommendations but a narrower booster emergency use authorization now seems likely.

6 Takeaways From 2021 PBMI Annual National Conference

September 17th 2021

The specialty drug spend and data flow and connectivity were among the themes of the presentations given at the hybrid conference this week in Orlando, Florida.

ICER Foresees AstraZeneca’s Tezepelumab for Severe Asthma As Being Only Modestly Cost Effective

September 17th 2021

Tezepelumab, which is being currently reviewed by the FDA, provides small improvements in daily symptoms and quality of life but is only modestly cost-effectiveness at the anticipated price, according to the cost-effectiveness group's calculations.

AI: Beyond the Buzz

September 17th 2021

Artificial intelligence is improving healthcare methods and insights. But when used incorrectly, AI is rife with pitfalls.

Ibrance Shows Promise in Treatment of Myelofibrosis

September 17th 2021

An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.